Manufacturing roundup: Andelyn Biosciences opens new facility in Ohio; Novo warns of Ozempic counterfeit
Andelyn Biosciences, a cell and gene therapy CDMO, has opened a new manufacturing headquarters in Columbus, OH.
The new 180,000-square-foot facility is home to Andelyn …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.